2026 Q2 Portfolio Activity
In 2026 Q2, DIADEMA PARTNERS LP maintained a portfolio of 212 distinct positions. The most significant new addition was BRISTOL-MYERS SQUIBB CO, now representing 4.37% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing the position by 359.8%. Conversely, DIADEMA PARTNERS LP completely exited their position in VERTEX PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
DIADEMA PARTNERS LP
AUM $265M
Total Positions
212
Quarter
2026 Q2
Top Holding
VKTX (6.0%)
Top 10 Concentration
37.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 212
DIADEMA PARTNERS LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VKTX
CALL
VIKING THERAPEU...
|
CALL Option | 6.02% | 3.65% |
#1
3
Prev: #4
|
7.4 |
—
|
561,600 | 85.2% |
P
S
|
1,220,800 | $47,623,408 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
CALL
ABIVAX SA
|
CALL Option | 5.88% | 1.89% |
#2
14
Prev: #16
|
6.9 |
—
|
249,200 | 249.2% |
P
S
|
349,200 | $46,534,392 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMY
CALL
BRISTOL-MYERS S...
|
CALL Option | 4.37% | — |
#3
Prev: #—
|
6.2 |
—
|
600,000 | — |
NEW
|
600,000 | $34,572,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
PUT
ABIVAX SA
|
PUT Option | 4.25% | 1.89% |
#4
13
Prev: #17
|
5.2 |
—
|
152,400 | 152.4% |
P
S
|
252,400 | $33,634,824 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.63% | 2.75% |
#5
4
Prev: #9
|
5.0 |
—
|
25,686 | 94.1% |
P
S
|
52,989 | $28,711,030 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 3.29% | 1.34% |
#6
21
Prev: #27
|
4.3 |
—
|
58,346 | 72.1% |
P
S
|
139,218 | $26,072,747 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 2.73% | 1.40% |
#7
18
Prev: #25
|
4.1 |
—
|
87,700 | 115.5% |
P
S
|
163,644 | $21,598,038 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.41% | 2.11% |
#8
4
Prev: #12
|
4.0 |
—
|
170,900 | 52.9% |
P
S
|
493,664 | $19,104,797 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMY
PUT
BRISTOL-MYERS S...
|
PUT Option | 2.41% | — |
#9
Prev: #—
|
4.5 |
—
|
330,600 | — |
NEW
|
330,600 | $19,049,172 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
BRIDGEBIO PHARM...
|
|
Bond/Debt | 2.35% | 3.16% |
#10
3
Prev: #7
|
1.9 |
—
|
no change | no change |
P
S
|
250,000 | $18,620,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CORT
CALL
CORCEPT THERAPE...
|
CALL Option | 2.27% | 1.09% |
#11
21
Prev: #32
|
3.4 |
—
|
47,800 | 30.2% |
P
S
|
206,300 | $17,937,785 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 2.26% | 1.42% |
#12
12
Prev: #24
|
3.9 |
—
|
164,617 | 111.1% |
P
S
|
312,846 | $17,901,048 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 2.18% | 2.91% |
#13
5
Prev: #8
|
1.4 |
—
|
-83,373 | -15.9% |
P
S
|
441,808 | $17,234,930 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KYMR
CALL
KYMERA THERAPEU...
|
CALL Option | 2.17% | — |
#14
Prev: #—
|
4.4 |
—
|
149,700 | — |
NEW
|
149,700 | $17,166,099 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVS
PUT
NOVARTIS AG
|
PUT Option | 1.98% | — |
#15
Prev: #—
|
4.3 |
—
|
100,000 | — |
NEW
|
100,000 | $15,672,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
PUT
UNIQURE NV
|
PUT Option | 1.74% | 0.83% |
#16
24
Prev: #40
|
1.7 |
—
|
no change | no change |
P
S
|
299,000 | $13,771,940 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
PUT
VIKING THERAPEU...
|
PUT Option | 1.73% | — |
#17
Prev: #—
|
4.2 |
—
|
350,500 | — |
NEW
|
350,500 | $13,673,005 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIIB
CALL
BIOGEN INC
|
CALL Option | 1.64% | — |
#18
Prev: #—
|
4.2 |
—
|
60,000 | — |
NEW
|
60,000 | $12,963,600 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CAPR
PUT
CAPRICOR THERAP...
|
PUT Option | 1.63% | 3.22% |
#19
14
Prev: #5
|
1.2 |
—
|
-89,000 | -14.3% |
P
S
|
534,400 | $12,868,352 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SMMT
CALL
SUMMIT THERAPEU...
|
CALL Option | 1.58% | — |
#20
Prev: #—
|
4.1 |
—
|
860,200 | — |
NEW
|
860,200 | $12,533,114 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
PUT
ELI LILLY & CO
|
PUT Option | 1.52% | — |
#21
Prev: #—
|
4.1 |
—
|
10,000 | — |
NEW
|
10,000 | $11,994,300 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INCY
PUT
INCYTE CORP
|
PUT Option | 1.51% | 1.69% |
#22
2
Prev: #20
|
1.6 |
—
|
no change | no change |
P
S
|
105,400 | $11,948,144 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.40% | — |
#23
Prev: #—
|
4.1 |
—
|
272,214 | — |
NEW
|
272,214 | $11,060,055 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
CALL
UNIQURE NV
|
CALL Option | 1.37% | 0.70% |
#24
18
Prev: #42
|
1.0 |
—
|
-14,600 | -5.8% |
P
S
|
235,400 | $10,842,524 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BNTX
CALL
BIONTECH SE
|
CALL Option | 1.18% | — |
#25
Prev: #—
|
4.0 |
—
|
100,000 | — |
NEW
|
100,000 | $9,305,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 1.07% | 1.25% |
#26
2
Prev: #28
|
2.4 |
—
|
25,155 | 13.0% |
P
S
|
218,117 | $8,497,838 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.02% | 0.99% |
#27
8
Prev: #35
|
2.9 |
—
|
61,674 | 31.9% |
P
S
|
254,863 | $8,091,900 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CAPR
CALL
CAPRICOR THERAP...
|
CALL Option | 1.00% | 1.70% |
#28
9
Prev: #19
|
1.4 |
—
|
no change | no change |
P
S
|
329,300 | $7,929,544 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVS
CALL
NOVARTIS AG
|
CALL Option | 0.99% | — |
#29
Prev: #—
|
3.9 |
—
|
50,000 | — |
NEW
|
50,000 | $7,836,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REPL
CALL
REPLIMUNE GROUP...
|
CALL Option | 0.97% | 0.27% |
#30
41
Prev: #71
|
3.4 |
—
|
490,800 | 238.8% |
P
S
|
696,300 | $7,708,041 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KOD
CALL
KODIAK SCIENCES...
|
CALL Option | 0.97% | 0.00% |
#31
111
Prev: #142
|
3.4 |
—
|
196,500 | 98250.0% |
P
S
|
196,700 | $7,663,432 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 0.96% | — |
#32
Prev: #—
|
3.9 |
—
|
571,107 | — |
NEW
|
571,107 | $7,595,723 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MRNA
PUT
MODERNA INC
|
PUT Option | 0.88% | 1.38% |
#33
7
Prev: #26
|
0.4 |
—
|
-59,400 | -37.3% |
P
S
|
100,000 | $7,003,000 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HIMS
CALL
HIMS & HERS HEA...
|
CALL Option | 0.88% | — |
#34
Prev: #—
|
3.9 |
—
|
200,000 | — |
NEW
|
200,000 | $6,934,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 0.87% | 0.88% |
#35
3
Prev: #38
|
0.8 |
—
|
-14,332 | -6.0% |
P
S
|
223,810 | $6,900,062 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HIMS
PUT
HIMS & HERS HEA...
|
PUT Option | 0.85% | — |
#36
Prev: #—
|
3.8 |
—
|
193,700 | — |
NEW
|
193,700 | $6,715,579 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRBP
CALL
CORBUS PHARMACE...
|
CALL Option | 0.75% | 0.18% |
#37
45
Prev: #82
|
3.3 |
—
|
518,500 | 449.7% |
P
S
|
633,800 | $5,945,044 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLS
CALL
SELLAS LIFE SCI...
|
CALL Option | 0.75% | 0.22% |
#38
41
Prev: #79
|
2.8 |
—
|
100,000 | 33.3% |
P
S
|
400,000 | $5,904,000 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KOD
PUT
KODIAK SCIENCES...
|
PUT Option | 0.72% | 1.60% |
#39
17
Prev: #22
|
0.3 |
—
|
-100,000 | -40.5% |
P
S
|
146,900 | $5,723,224 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
CALL
ALUMIS INC
|
CALL Option | 0.71% | 0.37% |
#40
17
Prev: #57
|
3.3 |
—
|
100,000 | 100.0% |
P
S
|
200,000 | $5,628,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RPRX
CALL
ROYALTY PHARMA ...
|
CALL Option | 0.71% | — |
#41
Prev: #—
|
3.8 |
—
|
100,000 | — |
NEW
|
100,000 | $5,607,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 0.71% | 2.24% |
#42
31
Prev: #11
|
0.3 |
—
|
-31,771 | -59.1% |
P
S
|
22,000 | $5,587,340 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REPL
PUT
REPLIMUNE GROUP...
|
PUT Option | 0.70% | 0.60% |
#43
2
Prev: #45
|
2.3 |
—
|
42,600 | 9.3% |
P
S
|
502,500 | $5,562,675 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
CALL
BIOAGE LABS INC
|
CALL Option | 0.62% | — |
#44
Prev: #—
|
3.7 |
—
|
200,100 | — |
NEW
|
200,100 | $4,904,451 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NVO
NOVO-NORDISK A ...
|
Healthcare | 0.61% | 0.09% |
#45
62
Prev: #107
|
3.2 |
—
|
85,423 | 586.0% |
P
S
|
100,000 | $4,809,442 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BHVN
CALL
BIOHAVEN LTD
|
CALL Option | 0.60% | 0.46% |
#46
5
Prev: #51
|
1.2 |
—
|
no change | no change |
P
S
|
317,000 | $4,716,960 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TENX
CALL
TENAX THERAPEUT...
|
CALL Option | 0.56% | — |
#47
Prev: #—
|
3.7 |
—
|
307,000 | — |
NEW
|
307,000 | $4,466,850 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.56% | 0.61% |
#48
5
Prev: #43
|
2.7 |
—
|
50,000 | 20.4% |
P
S
|
294,811 | $4,404,476 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.55% | — |
#49
Prev: #—
|
3.7 |
—
|
230,677 | — |
NEW
|
230,677 | $4,315,967 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TGTX
CALL
TG THERAPEUTICS...
|
CALL Option | 0.53% | — |
#50
Prev: #—
|
3.7 |
—
|
75,700 | — |
NEW
|
75,700 | $4,158,958 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 212 holdings